| A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse WKA Yung, RE Albright, J Olson, R Fredericks, K Fink, MD Prados, ... British journal of cancer 83 (5), 588-593, 2000 | 1205 | 2000 |
| Practice parameter: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumors [RETIRED] Report of the Quality Standards Subcommittee of the American Academy of … MJ Glantz, BF Cole, PA Forsyth, LD Recht, PY Wen, MC Chamberlain, ... Neurology 54 (10), 1886-1893, 2000 | 1016 | 2000 |
| Association of the extent of resection with survival in glioblastoma: a systematic review and meta-analysis TJ Brown, MC Brennan, M Li, EW Church, NJ Brandmeir, KL Rakszawski, ... JAMA oncology 2 (11), 1460-1469, 2016 | 898 | 2016 |
| A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors MJ Glantz, KA Jaeckle, MC Chamberlain, S Phuphanich, L Recht, ... Clinical cancer research 5 (11), 3394-3402, 1999 | 680 | 1999 |
| Randomized phase II study of cilengitide, an integrin-targeting arginine-glycine-aspartic acid peptide, in recurrent glioblastoma multiforme DA Reardon, KL Fink, T Mikkelsen, TF Cloughesy, A O'Neill, S Plotkin, ... Journal of clinical oncology 26 (34), 5610-5617, 2008 | 581 | 2008 |
| Cerebrospinal fluid cytology in patients with cancer: minimizing false‐negative results MJ Glantz, BF Cole, LK Glantz, J Cobb, P Mills, A Lekos, BC Walters, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 1998 | 532 | 1998 |
| Randomized trial of a slow-release versus a standard formulation of cytarabine for the intrathecal treatment of lymphomatous meningitis MJ Glantz, S LaFollette, KA Jaeckle, W Shapiro, L Swinnen, JR Rozental, ... Journal of Clinical Oncology 17 (10), 3110-3116, 1999 | 488 | 1999 |
| Anti‐Ri: an antibody associated with paraneoplastic opsoclonus and breast cancer FA Luque, HM Furneaux, R Ferziger, MK Rosenblum, SH Wray, ... Annals of Neurology: Official Journal of the American Neurological …, 1991 | 446 | 1991 |
| Early necrosis following concurrent Temodar and radiotherapy in patients with glioblastoma MC Chamberlain, MJ Glantz, L Chalmers, A Van Horn, AE Sloan Journal of neuro-oncology 82, 81-83, 2007 | 414 | 2007 |
| Neoadjuvant chemotherapy for muscle-invasive bladder cancer: a systematic review and two-step meta-analysis M Yin, M Joshi, RP Meijer, M Glantz, S Holder, HA Harvey, M Kaag, ... The oncologist 21 (6), 708-715, 2016 | 409 | 2016 |
| Treatment of radiation‐induced nervous system injury with heparin and warfarin MJ Glantz, PC Burger, AH Friedman, RA Radtke, EW Massey, ... Neurology 44 (11), 2020-2020, 1994 | 390 | 1994 |
| High-dose intravenous methotrexate for patients with nonleukemic leptomeningeal cancer: is intrathecal chemotherapy necessary? MJ Glantz, BF Cole, L Recht, W Akerley, P Mills, S Saris, F Hochberg, ... Journal of Clinical Oncology 16 (4), 1561-1567, 1998 | 364 | 1998 |
| Neutrophil-induced ferroptosis promotes tumor necrosis in glioblastoma progression PP Yee, Y Wei, SY Kim, T Lu, SY Chih, C Lawson, M Tang, Z Liu, ... Nature communications 11 (1), 5424, 2020 | 258 | 2020 |
| A randomized, blinded, placebo-controlled trial of divalproex sodium prophylaxis in adults with newly diagnosed brain tumors MJ Glantz, BF Cole, MH Friedberg, E Lathi, H Choy, K Furie, W Akerley, ... Neurology 46 (4), 985-991, 1996 | 238 | 1996 |
| Recurrent meningioma: salvage therapy with long-acting somatostatin analogue MC Chamberlain, MJ Glantz, CE Fadul Neurology 69 (10), 969-973, 2007 | 229 | 2007 |
| Diagnostic tools for neoplastic meningitis: detecting disease, identifying patient risk, and determining benefit of treatment MC Chamberlain, M Glantz, MD Groves, WH Wilson Seminars in oncology 36, S35-S45, 2009 | 224 | 2009 |
| Identification of early recurrence of primary central nervous system tumors by [18F]fluorodeoxyglucose positron emission tomography MJ Glantz, JM Hoffman, RE Coleman, AH Friedman, MW Hanson, ... Annals of neurology 29 (4), 347-355, 1991 | 220 | 1991 |
| Diagnosis, management, and survival of patients with leptomeningeal cancer based on cerebrospinal fluid‐flow status MJ Glantz, WA Hall, BF Cole, BS Chozick, CM Shannon, L Wahlberg, ... Cancer 75 (12), 2919-2931, 1995 | 214 | 1995 |
| A randomized double-blind placebo-controlled phase II trial of dendritic cell vaccine ICT-107 in newly diagnosed patients with glioblastoma PY Wen, DA Reardon, TS Armstrong, S Phuphanich, RD Aiken, ... Clinical Cancer Research 25 (19), 5799-5807, 2019 | 207 | 2019 |
| Temozolomide as an alternative to irradiation for elderly patients with newly diagnosed malignant gliomas M Glantz, M Chamberlain, Q Liu, NS Litofsky, LD Recht Cancer: Interdisciplinary International Journal of the American Cancer …, 2003 | 174 | 2003 |
